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Abstract 
Background 
High-throughput mass spectrometric (HT-MS) study is the method of choice for monitoring 
global changes in proteome. Data derived from these studies are meant for further validation 
and experimentation to discover novel biological insights. Here we evaluate use of relative 
solvent accessible surface area (rSASA) and DEPTH as indices to assess experimentally 
determined phosphorylation events deposited in PhosphoSitePlus. 
Results 
Based on accessibility, we map these identifications on allowed (accessible) or disallowed 
(inaccessible) regions of phosphoconformation. Surprisingly a striking number of HT-
MS/MS derived events (1461/5947 sites or 24.6%) are present in the disallowed region of 
conformation. By considering protein dynamics, autophosphorylation events and/or the 
sequence specificity of kinases, 13.8% of these phosphosites can be moved to the allowed 
region of conformation. We also demonstrate that rSASA values can be used to increase the 
confidence of identification of phosphorylation sites within an ambiguous MS dataset. 
Conclusion 
While MS is a stand-alone technique for the identification of vast majority of 
phosphorylation events, identifications within disallowed region of conformation will benefit 
from techniques that independently probe for phosphorylation and protein dynamics. Our 
studies also imply that trapping alternate protein conformations may be a viable alternative to 
the design of inhibitors against mutation prone drug resistance kinases. 
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Background 
Phosphorylation is a reversible post translational modification of proteins that regulates many 
vital process like cell cycle, cell proliferation, signal transduction and cell death to name a 
few [1-3]. It is also a fundamental mechanism by which a message from a small set of genes 
is translated into pathway based spatio-temporal regulation of cellular function [4-6]. At least 
1/3 rd of cellular proteins are estimated to be phosphorylated often at more than one site [7,8]. 
Therefore the need for characterizing global changes in phosphorylation cannot be 
overemphasized and it is a basic requirement for understanding functional biology at systems 
level [5,9-11]. By such criteria these studies are not an end but the beginning of the way in 
which science will be conducted and interpreted increasingly in the future. Multiple 
techniques and knowledge from several disciplines like biochemistry, biophysics, structural 
and cell biology, computational and bioinformatic studies will be necessary for integrated and 
comprehensive understanding of biology and its intervention. 
With the advent of fast high resolution liquid chromatography (LC) techniques, identification 
of global changes in the proteome such as post-translational modifications by LC-MS has 
become the method of choice [10,12-15]. Identification of phosphorylation by HT-LC-MS is 
primarily dependent on the use of accurate mass of the peptide, sequence from tandem MS 
and a search for its match within a theoretically generated database of proteins [5,12,13]. 
Assignment relies on probability scores [16,17]. Until recently, probable errors within HT-
MS data could only be verified manually [18]. Errors in such large scale identifications have 
been considerably reduced by technological advancements that ensure high accuracy of 
identification, enrichment of phosphorylated proteins using metal affinity columns, 
quantifying relative proportions of the phosphorylated and unphosphorylated species and 
integration of new bioinformatic methods and algorithms into search engines [15,18-24]. 
Despite all these approaches and stringent rules imposed by the investigators, like all other 
HT studies, some false positive and false negative identification of phosphorylation sites is 
inevitable. As the amount of information on proteome wide phosphorylation is being 
gathered at a rapid rate, validation of these identifications remains a concern and a challenge. 
Besides it is expected for the future of mass spectrometry that the technique stands validated 
on its own. 
To address this issue we chose to apply some of the fundamental structural rules to a vast 
depository of MS derived data, PhosphoSitePlus, on protein phosphorylation. We simply 
asked how many of the identified phosphosites are in compliance with a major structural rule, 
that is, degree of solvent accessibility. Accessibility of phosphorylation sites in proteins and 
conformational changes induced by phosphorylation have been addressed before [25-27]. 
Phosphorylation has been detected mostly in flexible, disordered [28] and in accessible 
regions of the protein [29]. Few elegant studies have described the structural basis of 
phosphorylation [25,30,31]. Conformational changes in proteins before and after 
phosphorylation [25,26] have been demonstrated using crystal structures of the same protein 
in its unphosphorylated and phosphorylated forms. Yet to the best of our knowledge there is 
no comprehensive analysis of structures of a large body of MS derived phosphosites and its 
application for subjective validation of experimentally determined phosphosites. Information 
from structural analysis would be unbiased as it is blind to the source of data and more 
importantly it is blind to the technique of MS employed. Since solvent or surface accessibility 
of a sequence is one of the fundamental requirements for a kinase mediated phosphorylation, 
we asked the following: to what extent can the existing structural information help to identify 
genuine phosphorylation sites? 
Results and discussion 
Analysis of the phosphorylated sequences from the PhosphoSitePlus 
One of the primary requirements for a site to get phosphorylated is its accessibility to a 
kinase, a parameter, that can be calculated using Solvent Accessible Surface Area or SASA 
of a sequence for which structural information is available. Phosphosequences from 
PhosphoSitePlus were downloaded, matched with the PDB data base and coordinates were 
used for calculating rSASA using Parameter Optimized Surfaces in the stand alone mode. For 
the a few proteins (2.3%) the matched structures were of the phosphorylated sequence but for 
majority of others (97.7%) they were of non phosphorylated forms. SASA values and rSASA 
values were extracted in the context of the octapeptide where phosphorylated residue 
occupies the 4th position. SASA value has been previously used to evaluate phosphorylation 
events in mitotic check point proteins [29], by us to identify novel substrates of 
endoproteases [32] and by the Craig and Sali group for the identification of Granzyme 
substrates [33]. Out of 16,528 unique phosphorylation sites in the phosphosite database 3579 
sites were present in the disordered region (no co-ordinates) and 315 sites were present at the 
extreme termini (Additional file 1: Figure S1 and Table S1). Phosphorylation at these sites by 
a kinase is highly likely and thus stands validated by criteria of accessibility. For other sites 
where co-ordinates were available for the octapeptide sequence (please see methods), only 
protein structures which covered 70% of the primary sequence were considered. This 
stringency narrowed down the study to 5947 sites which were further analyzed using a 
reference data set of proteins created from Protein Data Base (PDB) with solved crystal 
structure of phosphorylated residues (Additional file 1: Table S2). 
Comparative analysis of PDB and Phosphosite 
In the PDB, 282 unique phosphorylation sites were found within prokaryotic, eukaryotic, 
bacterial and viral proteins (Additional file 1: Table S2). In these proteins besides 
Ser/Thr/Tyr (conventional) residues Asp/His/Cys residues (unconventional) were also 
phosphorylated. Conventional and unconventional phosphorylation sites from Pro and 
eukaryotic proteins were independently segregated. Conventional phosphorylation of the 
eukaryotic proteins from the PDB database and PhosphoSitePlus were then compared. Data 
were binned in blocks of 0.1 rSASA units (0–0.1, 0.1-0.2 etc. upto 0.9-1.0). The mode for the 
PDB data lies in the range of 0.4-0.5 and for phosphosite it is in the range of 0.2-0.3 (Figure 
1A). The median for the PDB data is 0.42 and for phosphosite it is centered on 0.3. 
Figure 1 Comparative analysis of PDB and Phosphosite-plus datasets. A) rSASA values 
from Phosphosite-plus and PDB datasets were binned at regular intervals with a difference of 
0.1. Data from phosphosite-plus were plotted on Y1 axis and those from PDB were plotted on 
Y2 axis. Majority of phosphorylation sites in PDB dataset are in well accessible regions of 
the protein while in PhosphoSitePlus, they are found in moderately accessible regions. 
Representative structures where different phosphosites are found in three different regions of 
accessibility are shown. B) Actin protein (PDBID: 1 T44) where the site lies in inaccessible 
region (rSASA: 0.11), in C, carbonic anhydrase II (PDBID: 1XEV) the site is in a moderately 
accessible region (rSASA: 0.3) and in D, recombining binding protein suppressor of hairless 
(PDBID: 3NBN), in a well accessible region (0.73). All protein structures were fetched from 
PDB by matching the Uniprot ID of the protein from the phosphosite data. Distribution of 
octapeptide secondary structure and their accessibility. E) Octapeptides from Phosphosite-
plus dataset and F) Octapeptides from the PDB dataset. 
While most (58.4%) of the experimentally determined phosphorylation sites occur in 
moderately accessible (0.2-0.4) regions of proteins, the PDB is marked by (54.47%) 
phosphorylated residues in more accessible regions (0.4-0.7). This distribution was verified 
after energy minimization of the structures and the results remain the same (Additional file 1: 
Figure S2). Representative protein structures in which the phosphosite lies in this range of 
rSASA values are shown in Figure 1B, C, D. In protein Actin (PDB 1 T44), the site is in an 
inaccessible region (0.11), while in carbonic anhydrase II (PDB 1XEV), the site is in a 
moderately accessible (0.3) region and the phosphosite in recombining binding protein 
suppressor of hairless (PDB 3NBN), is in a well accessible region (0.73). 
Even within the PDB, number of sites within the highly accessible region (>0.7) is rather 
small. Remarkably a significant amount of phosphorylation events occur in relatively 
inaccessible regions of the protein (rSASA < 0.2). PDB protein structures are of 
phosphorylated forms. Therefore this inaccessibility in some cases may be due to the 
conformational changes induced by phosphorylation. Sequestration of a phosphorylation site 
could be an evolutionary strategy evolved to protect these sites from indiscriminate or 
untimely dephosphorylation. PhosphoSitePlus on the other hand is predominantly represented 
in the PDB in their unphosphorylated forms which may be different from the corresponding 
phosphorylated structures. Therefore presence of these sequences in relatively less accessible 
regions of the protein prior to phosphorylation is surprising. 
Observed differences in the pattern of distribution of rSASA values between PDB and 
phosphosite data is also reflected in the secondary structural properties of the phosphorylated 
sequences. PDB sequences are enriched in turn/coil conformation (79.7%) while phosphosite 
is populated in helical structures (38.14% helix and 39.7% turn) and to a lesser extent by beta 
sheets (20.1%) which may explain lower accessibility values (Figure 1E and F). Abundance 
of helical structures in phosphorylation sites has not been noted before. 
Conformational Map of phosphorylation 
To better understand the distribution of rSASA values and to define a lower limit above 
which a kinase mediated phosphorylation can be considered likely, we analyzed the PDB data 
set more carefully. rSASA values obtained from conventional and unconventional 
phosphorylation sites were plotted (Figure 2A). Regardless of their origin rSASA values of 
unconventional phosphorylation sites were always less than 0.3 (21/23). A significant 
percentage of conventional phosphorylation sites (7.1%) in the eukaryotes had rSASA values 
<0.3 indicating lesser accessibility/inaccessibility of these sites. As mentioned before, it is 
possible that post-phosphorylation these sequences may have moved into the buried region of 
the protein. However there is no overwhelming evidence to extrapolate this explanation to all 
such examples. 
Figure 2 Conformational map of the phosphoproteome. A) Phosphorylated proteins in the 
PDB data set were classified under eukaryotes and prokaryotes. These were further 
subdivided in to subsets of conventional (Eu_S/T/Y, Pro_S/T/Y) and unconventional 
(Eu_H/C/D, Pro_H/C/D) phosphorylation sites. All subsets were binned with size interval of 
0.1. Majority of eukaryotic conventional phosphorylation sites registered rSASA values >0.2. 
The rSASA values were also calculated for the single residues Ser, Thr and Tyr from 
phosphosite data B) and from the PDB data C). 
A careful look at the conventional phosphorylation indicates a bi-modal distribution. After a 
major peak centered on 0.4-0.5 (Figure 2A), there is decrease in phosphosites within the 0.5-
0.6 bin, followed by a small increase in number of proteins with rSASA values between 0.6 
and 0.7. We addressed this issue by considering the preferential abundance of Ser, Thr and 
Tyr phosphorylations. Residue level rSASA values were calculated for the PDB and 
PhosphoSitePlus data bases (Figure 2B and C). The observed bias is not a reflection of the 
type of residues that is phosphorylated and the bimodal distribution is consistently seen only 
with the PDB data base and not the phosphosite data. No plausible explanation seems 
obvious at this time. 
To explain the presence of phosphor residues with rSASA values less than 0.3 within the 
PDB data set, we surveyed the literature (Additional file 1: Table S3). Following facts were 
observed a) for some of these phosphorylation sites electron density could be assigned to 
another functional group for example strontium or sulphur, b) phosphorylation was not 
intended or expected at that site and therefore may not be enzymatic, c) few represent 
autophosphorylation events in kinases and d) these events represent structural intermediates 
that were inadvertently captured but the origin of phosphorylation remains a mystery. For 
example for PDB id 1MKI, authors comment that observed phosphorylation by 
crystallography was not a consistent event and number of attempts to confirm this through 
mass spectrometry were apparently unsuccessful [34]. 
Out of the 15 conventional phosphorylation events within the eukaryotic proteins with 
rSASA value less than 0.3 in the PDB data set, kinase mediated autophosphorylation could 
account for 9 cases. Six other proteins were non-kinases in which three of the phosphosites 
record rSASA values between 0.2 and 0.25 (Additional file 1: Table S3) and three below 0.2. 
Based on this analysis a stringent criterion to determine the feasibility of a kinase mediated 
phosphorylation event would be rSASA of ≥0.3.With this stringent cut off, 2636 i.e., 44.3% 
phosphosites with rSASA values ≤0.3 will have to be considered as non-kinase mediated. 
Such a conclusion can be misleading because a) it overemphasizes the importance of 
structural information in analyzing experimentally determined phosphorylation sites; b) 
kinases recognize their phosphorylation sites from a dynamic population of protein 
conformations, and static crystal structures by and large do not account for such 
conformational freedom (exceptions are discussed below) and c) as mentioned before ~54% 
of experimentally determined phosphosites are in relatively less accessible regions of the 
protein (0.2-0.4). Based on the above arguments we decided that 0.2 would be the minimal 
rSASA requirement for a kinase mediated phosphorylation event. 
With this limit we describe a conformational map under which all experimentally determined 
phosphorylation events can be grouped- a) disallowed region of phosphoconformation or 
zone of inaccessibility (with less than 0.2 rSASA) and b) allowed region of 
phosphoconformation or zone of accessibility (rSASA > 0.2; numbers). 75.4% or 4486 out of 
5947 unique phosphorylation sites (with >70% amino acid coverage in the structure) from the 
PhosphoSitePlus belong to the allowed region of conformation and stand validated. 
1461(24.6%) phosphosites belong to the disallowed region of conformational space. 
Compared to the phosphosite data, the number of matched structures available for the study is 
small (5947). Nevertheless the number of phosphorylation sites found within disallowed 
region of phosphoconformation (1461) is striking. If this observation were to be directly 
extrapolated to the total number of phosphorylation sites in the data base, ~53,770 
phosphorylation events would fall under disallowed region of conformation (even with 
rSASA < 0.2, a low stringent cut off)! Substantial and vast conformational changes or even 
partial unfolding would be absolutely necessary to expose these phosphorylation sites to 
kinases! Therefore phosphorylation events within the disallowed region of 
phosphoconformation demand additional explanation/s. 
In order to rule out the possibility that presence of these phosphorylation sites within 
inaccessible region may be a reflection of an inadvertent bias in the type and nature of the 
proteins that can be crystallized, phosphosites with and without PDB structures were 
classified under Panther pathway classification [35]. PDB seems to well represent most of the 
functional classes of proteins found within the phosphosite (Additional file 1: Table S4) 
indicating that our observations are not biased by the overabundance of a particular class of 
proteins. PhosphoSitePlus is a depository of both high and less well curated phosphorylation 
sites (CSA MS) from human and mouse [36]. To rule out the possibility that inaccessibility 
could be a reflection of level of curation we segregated this data into HTP MS with Pubmed 
reference only, CSA MS data only and those with records from both data set and classified 
them on the conformational map. Percent distribution of proteins within the disallowed 
region of conformation was not dependent on the level of curation (Additional file 1: Table 
S5) and for the rest of analysis all data are treated similarly. 
Conformational freedom in proteins 
PDB is a redundant data base with crystal structures of the same protein solved multiple 
times under the same or different conditions [37,38]. As demonstrated by a number of studies 
these are store houses of information on dynamic changes in protein conformation [37,39]. 
Large scale changes in protein conformation have been well documented by solving 
structures of proteins in their different oligomeric forms or in their ligand bound 
conformation [40]. By the same arguments, phosphorylation sites within the disallowed 
region of conformation may be inaccessible because a) they are at the interface of a protein 
complex (Figure 3A). b) A sequence present in an inaccessible region of the protein (in the 
disallowed region of phosphoconformation) in one structure may be present in an accessible 
region of the protein (allowed region of phosphoconformation) in another structure (Figure 
3B). For example in Figure 3B a phosphosite is buried to such an extent (PDB 2B3O) that in 
order to make this site accessible the protein will have to undergo large scale conformational 
change. PDB 3PS5 indeed shows that the sequence has moved to a different region of the 
protein surface where it is now accessible. In another example (PDB 2OJJ versus 2E14) order 
to disorder transition of the overhanging sequence captured in an alternate structure (Figure 
3C), exposes residues to the solvent and therefore to a kinase. Small local structural changes 
can also expose a previously inaccessible site (Figure 3D). Conversely reverse changes in 
structure would make these sequences inaccessible. Such inherent dynamism in protein 
structure is likely to fine tune signal induced phosphorylation which requires many factors 
and several rounds of amplifications to reach the right target. c) Kinase induced 
autophosphorylation can happen in the inaccessible region of a protein where the active site is 
in proximity to the site of phosphorylation (Figure 3E). This exception however may not 
always be applicable as seen in the context FGFR kinase. Crystal structure of this protein 
revealed autophosphorylation at several tyrosine residues. One of them according to our 
definition is present in the disallowed region of conformation. Doubting whether such 
phosphorylation is relevant in vivo as this would require ‘unfolding’ of the protein [41] 
authors of the structure calculated the stoichiometry of phosphorylation at different sites. It 
turns out that the stoichiometry at the buried site was less than that seen in more permissible 
sites of the protein [42]. 
Figure 3 Structures of a phosphosite from the disallowed and allowed region of 
conformation. A) Phosphorylation site in Catalase, a homo tetramer (PDB ID: 1QQW) is 
buried at interface and has a calculated rSASA of 0.18. We extracted the monomeric form of 
this protein and recalculated the rSASA value which is now 0.47 indicating that the site is 
now accessible. B) Protein Tyrosine-protein phosphatase has two conformations in which the 
phosphorylation site is buried in an auto inhibited (PDB ID: 2B3O) conformation with a 
rSASA value of 0.19 and it is accessible to the solvent (rSASA of 0.39) in an open 
conformation (PDB ID: 3PS5). C) Two structures of Mitogen-activated protein kinase 1 are 
aligned where the phosphosite is present adjacent to a segment which is ordered in one PDB 
and is disordered (PDBID: 2E14) in another conformation. The disordered segment lacks 
coordinates for the overhanging loop. The phosphosite has greater rSASA (0.35) in the 
structure with the disordered segment than in the ordered structure (0.16). D) Two different 
conformations of Voltage-dependent anion-selective channel protein 1 in which the local 
structural changes were observed at the site of phosphorylation. In PDBID: 2JK4 
phosphorylation site is buried inside channel (rSASA 0.13) whereas in PDBID: 2K4T 
phosphorylation the site is oriented outside (rSASA of 0.52). E) In Mitogen-activated protein 
kinase 3, the phosphosite is near to activation loop (rSASA 0.19). F) The phosphosite in 
Eukaryotic initiation factor has a known consensus pattern of S/T-P-X-K/R (rSASA 0.11) for 
Cyclin dependent kinase. The octapeptide is shown in ball and stick representation. In 
Figures A, B, C, D, E phosphosite is shown in ball and sphere notation and the 
phosphorylated residue is colored in black. 
By removing structural constraints mentioned above and excluding kinases, the number of 
proteins in the disallowed region can be reduced from 24.6% to 13.5%. In addition if the 
sequence of a phosphosite matches with known sequence specificity of a kinase but the site 
were to be buried in a crystal structure one may assume that within the cellular milieu the site 
was probably accessible in an alternate conformation (Figure 3F). Exclusion of such 
sequences reduces the number of protein in the disallowed conformation to 10.8%. 
The inherent dynamics of protein structures may also be sampled in an efficient manner using 
Cα-ENM Normal Mode Analysis as described in the Methods section. Since Cα-ENM 
Normal Mode Analysis is simple and computationally inexpensive, it provides a fast and 
automatable method to investigate the influence of protein conformation on rSASA and 
hence to further refine predictions about the accessibility of phosphorylation sites. This 
approach was tested on two groups of protein structures: a) four protein structures in which 
the proposed phosphorylation sites were classified as inaccessible on the basis of rSASA, but 
for which other structures had been reported with accessible phosphorylation sites; b) two 
proteins in which the phosphorylation sites were buried in all reported structures, which were 
selected as negative controls. For the two proteins in the negative control group (2AEB and 
1GZ3), rSASA of all of the conformers sampled by Cα-ENM Normal Mode Analysis was 
less than 0.1, which supports the classification of these proteins in the disallowed region of 
phosphoconformation. By contrast, two of the four proteins from group A have low-energy 
conformers with rSASA >0.2 (2B3O and 3PY1). Since kinases recognize their 
phosphorylation sites from a dynamic population of protein conformations, our results 
suggests that these proteins can be reclassified in the allowed region of 
phosphoconformation. The remaining two proteins show significantly larger changes in 
rSASA with protein conformation than the negative control group, but there is not enough 
evidence to reclassify these proteins based on the computational results alone. The results of 
these simulations are summarized in the Supporting Information (Additional file 1: Table 
S6). 
While the above analysis based on alternate structures and the normal mode analysis of 
proteins indicate that dynamism in protein structure can explain the apparent inaccessibility 
of a site, paucity of structural information of a large number of proteins, restricts direct 
extrapolation of this possibility to all phosphorylation events within a large data set like the 
PhosphoSitePlus. It is also unlikely that every MS derived data is a physiologically relevant 
identification. General knowledge on the physico chemical properties of proteins suggests 
that inaccessible and buried sequences are likely to be more hydrophobic than surface 
exposed sequences. This property was compared in phosphosites within allowed and 
disallowed region of conformation. Sequences within the disallowed regions were enriched in 
hydrophobic residues and correspondingly less in polar/charged residues (like aspartate or 
lysine), compared to those present in the allowed region of phosphoconformation (Additional 
file 1: Figure S3). If these sequences were to move and become exposed they are likely to 
render the protein unstable leading to aggregation. Additional experiments are therefore 
necessary to confirm phosphorylation at these sites. This is also reiterated by the normal 
mode analysis of two proteins with rSASA below 0.2 which showed that these sites are likely 
to remain inaccessible. 
Since some of these phosphosites in the accessible region of the protein can be close to the 
protein surface which may allow ready access to the surface under certain conditions, we 
used an alternative program called DEPTH [43] which measures the distance between a given 
residue and the non bonded water molecules at the surface of the proteins. Farther the residue 
from the protein surface, larger is the DEPTH value. We found that while proteins with 
rSASA of >0.2 scored DEPTH values less than 30, those with rSASA less than 0.2 scored 
values greater than 30 indicating that they are indeed far removed from the surface 
(Additional file 1: Table S7). 
To determine if proteins containing phosphosites with small rSASA values (disallowed 
conformation) would differ from the others (allowed conformation) in terms of the extent to 
which they can undergo conformational changes, we used a predictive measure for 
conformational changes as reported by Marsh et al., [44]. Greater the deviation from the 
theoretical estimates larger is the conformational change. Results are shown in Figure 4A. 
Arel greater than 1 reportedly indicates more flexibility or large conformational changes. 
Phosphosites within disallowed region show a higher frequency of distribution towards lesser 
Arel as compared to those within the allowed region. Proteins in which the phosphosites are 
within the allowed region seem more flexible than those within the disallowed region of 
phosphoconformation. It is interesting to note that even though some proteins in which the 
phosphosites are in the disallowed region are conformationally more malleable (Arel >0.1), 
the phosphosites themselves are inaccessible to a kinase indicating local conformational 
restriction. 
Figure 4 Global conformational flexibility versus local accessibility of phosphosite and 
conformational trapping by inhibitors. A) Protein flexibility or conformational changes 
were computed from the molecular weight of the proteins and compared with the 
experimentally determined SASA values for proteins from phosphosite data falling under 
disallowed (<0.2) and allowed region of phosphoconformation (>0.2). Arel was calculated as 
the ratio of experimentally determined SASA to the predicted SASA. Dark bars indicate 
proteins in disallowed region of phosphoconformation while the light bars indicate those in 
the allowed region of conformation. B) The concept of conformational trapping by kinases 
vis a vis inhibitors is depicted using the free energy landscape. Protein in which the 
phosphosite is inaccessible is imagined to be in a low energy stable state (1) and the same site 
however may become accessible in a similar (2) or a high energy state (3). These 
conformations can be trapped by a kinase leading to phosphorylation (4) which stabilizes the 
protein and lowers its free energy. The phosphorylated ‘active’ state of the protein is shown 
here at a higher energy level (5) than the conformation in which the phosphosite is 
inaccessible. Action of a phosphatase may relieve the excess energy. C) This cartoon depicts 
conformational trapping by inhibitors. An inhibitor can bind to an allosteric site in the 
disallowed region of phosphoconformation freezing the protein in this kinase inaccessible 
state. Other inhibitors may bind to similar or higher energy conformations in which the 
phosphosite is increasingly accessible howoever inhibitor binding induces conformational 
changes rendering the phsophosite inaccessible to a kinase. The kinase accessible site may 
also be trapped by inhibitors competing at the phosphosite (not shown). 
While analyzing phosphorylation status of mitotic check point proteins, Durbin group 
observed that phosphorylation sites are less seen in structured regions of the proteins [29]. 
However they also observed that 15% of all phosphosites exhibited less than 10% solvent 
accessibility of their side chains in the unmodified form of the protein. They specifically 
describe such examples where these sites are found in buried regions of the protein and allude 
to the fact that these sites are likely to have problems in acting as substrates. More 
importantly they point out that local amino-acid repacking will be necessary to accommodate 
different electrostatic and steric properties between the unmodified and modified 
phosphorylation sites. They describe a few possibilities through which such sites can be 
exposed to kinase including intrinsic flexibility or an active conformational change induced 
by binding of other proteins, cofactors or ligand. These are in line with our observations. 
It is in light of these observations that the following observations become very critical and 
intriguing. Many phosphorylation events within the phosphosite are seen at the interface of 
homo oligomeric proteins like a homo dimer or a tetramer [29,40]. If MS derived data is 
correct and physiologically relevant, then, phosphorylation must have occurred in the 
monomer which was accessible to the kinase under the experimental conditions. It is very 
difficult to prove the presence of monomeric forms of such proteins in cells. Due to their high 
affinity and sometimes interdependency of subunits to achieve the final folded form and 
stability, it is difficult to identify natively dissociated monomers in vitro. Such an attempt is 
often associated with protein unfolding or aggregation. On the other hand generation of such 
transient conformations in vivo may be coupled tightly with signaling events offering a great 
opportunity for the design of novel strategies to block kinase mediated signaling without 
targeting the kinase active site or their ATP binding site [45,46]. Data from alternate crystal 
structures indicate that it is possible to trap thermodynamically stable forms of conformations 
that are inaccessible to a kinase. One can imagine that an inhibitor may also bind to similar 
low energy conformation at an allosteric site, stabilizing the inaccessible/inactive 
conformation and prevent its transition into a kinase accessible form. These possibilities are 
represented in a cartoon form in Figure 4B and C. The cartoon is inspired by the popular and 
currently prevailing hypothesis that proteins exist as ensemble of conformers with varying 
degrees of free energy and one with the lowest energy is not necessarily the active form 
[47,48]. Presence of different conformers is envisaged to explain allostery, induced fit 
mechanisms and binding and selection by inhibitors some of which have been demonstrated 
by X-ray crystallography [49,50]. Many kinases more often than not are trapped in their 
inactive conformation by molecules that bind very close to the ATP binding site [51]. 
We imagine that the phosphosites within disallowed region of phosphoconformation sample 
conformational space of varying energy and the site may be accessible albeit in a transient 
high energy state or in a state of very similar energy (Figure 4B). A kinase may bind and trap 
these conformations and phosphorylate the protein. Inhibitors can bind to different states of 
the protein in this ensemble and freeze the protein in an inactive conformation (Figure 4C). 
Validation of an ambiguous data set 
It would be useful if crystal structure information could help in better discrimination of false 
positive and false negative data. We used a very high quality data set [18] where scores were 
provided for strength or ambiguity in MS identification. An ‘A’ score of <19 indicated 
ambiguity but >19 indicated high confident assignment [18]. Many of these identifications 
had single phosphorylation while others carried up to three phosphorylations. We found 
matches for 72 of these phosphorylation events within the PDB. All but one site with a score 
of > 19 were in the allowed region of phosphorylation indicating a near perfect match 
between MS data and accessibility. In a single case with an A score of (>19) and PDB id 
1I2M, the sequence was present in the disallowed region in all its available structures 
(Additional file 1: Table S8 and Figure S4A). Educated by our findings from the phosphosite 
data, we looked at this structure more carefully and found that the sequence was covered by 
an N terminus coil of 12 residues ranging from 24–35 numbering of PDB. If this region were 
dynamic, it would move away to readily expose these residues for phosphorylation. We 
deployed normal mode analysis and found that several of the low-energy Cα-ENM normal 
modes of 1I2M lead to conformers in which the N-terminal coil moves away from the 
phosphorylation site. For example, perturbation of the protein structure along the lowest-
frequency normal mode results in a transition of the flap region from a closed to an open 
conformation. However, none of the protein conformations sampled by Cα-ENM normal 
mode analysis place this protein in the allowed region of phosphoconformation (Additional 
file 1: Table S6). In the absence of support from existing structures it would be worthwhile to 
do additional experiments to monitor phosphorylation at this site using other independent 
techniques. It is noteworthy that this protein is cylindrical in shape with the octapeptide that 
surrounds the phosphorylation site lying length ways along the inside of the cylinder, which 
makes it relatively inaccessible to kinases. If the identification is indeed correct then it is very 
likely that a conformational change has been introduced in the protein under the experimental 
conditions by signaling or via protein-protein or protein-ligand interactions to name a few. Or 
the kinase may itself induce the necessary conformational change in the protein upon binding. 
Out of eight structures with an A score of <19, and considered ambiguous, seven belong to 
allowed region of phosphorylation (Additional file 1: Table S6 and Figure S4B). Our analysis 
indicates that these phosphorylation events are structurally feasible and are probably a 
physiological reality. We were fortunate to use these proteins because the authors themselves 
placed these proteins under the ambiguous category. As mentioned before there are several 
other phosphosites in Phsophosite plus that belong to the disallowed region of conformation 
that needs to be verified by other additional experiments. 
Conclusions 
In summary a very high percentage of MS data obeys common and inherent laws of protein 
structure required for kinase access. In a significant percentage of cases this rule does not 
holds true. For a few cases, in depth structural analysis and knowledge about conformational 
freedom and presence of redundant protein structures allows us to explain the discrepancy. 
Our detailed analysis of the PDB structures of phosphorylated sequences caution that sites 
within inaccessible regions of a protein are mostly biologically irrelevant or non-kinase 
mediated (Additional file 1: Table S3), enriched in hydrophobic residues prone to 
aggregation upon exposure. It would definitely be worthwhile to revisit the mass 
spectrometric data in such conflicting cases and further experiments may be needed to decide 
whether these are actually a kinase driven reaction or not. It is also important to use 
complementary techniques like NMR, sophisticated MD simulations other biophysical 
studies to better understand the fate of buried residues in post translational modifications 
[27,52]. 
A phosphorylation event within disallowed region of conformation is a true physiologically 
relevant conformation trapped by a kinase if a) an alternate structure is present where the site 
is accessible, and b) the sites have been identified by many independent investigators under 
different experimental conditions c) accuracy of detection has been ensured. It is possible to 
think of inhibitors which like the kinase, may trap such altered conformations that will 
prevent either a kinase mediated phosphorylation or inhibit protein-protein interaction leading 
to phenotypic consequences. These may be exploited for the design of inhibitors to prevent 
overactive kinase mediated signaling in diseases such as cancer. Such a strategy will be a 
viable alternative to currently available methods that target kinases which are however prone 
to mutational changes and therefore drug resistance leading to relapses or more severe forms 
of the disease. 
Methods 
PhosphoSitePlus dataset 
A total of 2,18,870 phosphosites were downloaded from Phosphosite-Plus database. From 
this source data set, 32,609 unique accession numbers covering all databases like Uniprot, 
NCBI, Ensembl were shortlisted. Independent match with the well curated Uniprot/SwissProt 
database fetched 27,678 unique accession numbers. The remaining 4931 entries failed 
because they were either isoforms or proteins are listed under Uniprot/Trembl, NCBI, and 
Ensembl databases. 
Matching phosphorylation sites from PhosphoSitePlus against the PDB 
From these 27,678 shortlisted proteins, those with available PDB structures were searched 
using a Perl script. Entries were available for 5131 proteins corresponding to 54,348 
phosphosites. In phosphositeplus these sites are represented in a 15 residue format such as 
XXXXXXX(S/T/Y)XXXXXXX. These were extracted and trimmed further to obtain 
octapeptides of the form XXX(S/T/Y)XXXX which were further analysed. Co-ordinates for 
these octapeptides could be located for 16,528 phosphorylation sites in 3,758 proteins. For 
the other 37,820 sites, the octapeptide sequences were not covered in the solved PDB 
structure and were not considered further. 
All the PDB files for the matched proteins were downloaded using download files tool 
available on PDB website (www.rcsb.org/pdb/download/download.do). PDB IDs were 
provided as input. Out of 16,528 phosphorylation sites, matches for 4162 sites failed because 
co-ordinates for some or all of the eight residues (disordered) were either absent or there was 
a mutation within the octapeptide sequence. In order to distinguish between the two 
possibilities, mutated residues were searched by a modified query. Here residue at each 
position was replaced by 19 other amino acids one at a time. These modified sequences were 
then matched back to the parent sequence. For example for the octapeptide ATGSELVD, the 
query sequence was altered by Mut1: XTGSELVD, Mut2: AXGSELVD, Mut3: 
ATXSELVD, Mut4: ATGXELVD, Mut5: ATGSXLVD, Mut6: ATGSEXVD, Mut7: 
ATGSELXD or Mut8: ATGSELVX where X is any one of the other 19 amino acids. By this 
method we could clearly differentiate between mutation and disordered regions. 583 sites 
carried a mutant sequence and 3579 sites were disordered. 
Relative solvent accessible surface area of octapeptide (rSASA) 
To ensure reliability, we limited our analysis to proteins for which structures were determined 
for at least 70% of the primary sequence. 5947 phosphorylation sites met with this criterion 
and were analyzed further using a stand-alone software called POPS for Parameter Optimised 
Surfaces [53]. rSASA for each octapeptide from PhosphoSitePlus were extracted from the 
corresponding complete files using perl scripts. The rSASA for each octapeptide was 
calculated as an average of%SASA which is the ratio between solvent accessible surface area 
(SASA) of a residue in its three dimensional structure and SASA of its extended tripeptide 
(Gly/Ala-X-Gly/Ala) conformation. To see whether energy minimization of PDB structures 
has any effect on calculated rSASA value, a set of 201 high resolution (> = 3.0) structures 
(covering 568 phosphosites) were energy minimized using GROMACS software with OPLS 
force field [54]. Residue level rSASA values were also calculated for S/T/Y phosphorylation 
for both PDB and Phosphosite data. 
To obtain a measure of conformational flexibility of proteins containing phosphosites with 
<0.2 rSASA and those with >0.2 rSASA, a predictive measure of relative solvent 
accessibility (Arel) as reported by from Marsh et al. [44], was used. Only monomers from our 
phosphosite dataset were considered and those with greater than 5 disordered residues were 
filtered. Observed SASA of a structure is calculated from AREAIMOL application from 
CCP4 package and predicted SASA is calculated by using Equation 4.44*M^0.77 where M is 
the mass of the protein. Arel = observed SASA / predicted SASA calculated as above. 
Secondary structure determination 
Similar protocol was followed for secondary structure determination using Stride stand-alone 
tool [55]. A representative secondary structure of the octapeptide would be HHTTEEC 
(helix-helix-turn-turn-sheet-sheet-coil). 
Preparation of PDB dataset containing phosphorylated residues 
PDB database was searched for a ‘modified residue’ within advanced search interface page 
provided at http://www.rcsb.org/pdb/search/advSearch.do. This search produced an output of 
16436 structures. Using perl scripts and searching specifically for Serine, Threonine, 
Tyrosine, Histidine, Cysteine, Aspartic acid residues a total of 1230 phosphorylated 
structures were fetched. 
If multiple chains were phosphorylated in the homo multimeric structures then a single chain 
was considered. Redundant structures were removed and only unique phosphosites were 
considered which resulted in 280 proteins. Out of this 280, 104 are phosphoserine, 76 are 
phosphothreonine, 77 are phosphotyrosine, 19 are phosphohistidine, 3 are phosphocysteine 
residues and one of them is aspartyl phosphate. 
Cα elastic network model - normal mode analysis 
To investigate the influence of protein conformation on rSASA, we used normal mode 
analysis of a Cα-Elastic Network Model (Cα-ENM) of protein structure to sample thermally 
accessible low-energy conformational states. A Cα-ENM is a coarse-grained model of protein 
structure in which each residue is represented by a single point located at its Cα atom 
coordinate [56,57]. Pairwise interactions between these coarse-grained points are computed 
using a harmonic potential of the form: 
( )0 012 ij c
N
ij ijd RE k d d<= −∑
  
where k is the force-constant, d0ij is the distance between Cα atoms i and j in the crystal 
structure of the protein, dij is the distance between these points in the elastic network model, 
RC is a distance cut-off such that only Cα atoms that are separated by less than this distance 
contribute to the potential energy, and N is the number of Cα atoms in the protein. In 
accordance with previous studies [58], we use R = 10 Å and a single value of k for all 
residues. The input coordinates of the Cα atoms of each protein were obtained from the 
RCSB PDB [59] with missing residues added using the program Prime. Once a Cα − ΕΝΜ 
has been defined for a protein, harmonic vibrational analysis can be performed using standard 
tools [60] leading to 3 N-6 eigenvectors (“normal modes”) with non-zero eigenvalues. 
Although Cα − ΕΝΜs are conceptually simple, there is substantial evidence that their low-
frequency (low-eigenvalue) normal modes are useful for studying large-scale conformational 
changes in proteins, and they have been used successfully in a wide-variety of applications, 
including biasing molecular dynamics simulations [61], sampling protein-flexibility in 
molecular docking [62], mapping conformational transitions [58], and fitting of atomic 
structures into low-resolution electron density maps [63]. 
Once the normal modes had been calculated from the Cα Elastic Network Model, a set of 
discrete molecular conformations were generated for each protein by permuting the crystal 
structure at small intervals along each of the twenty lowest-energy normal modes. The value 
of rSASA was then calculated for each of the discrete molecular conformations using the 
POPS software as discussed previously. In total, 401 distinct low-energy molecular 
conformers were generated for each protein (20 normal modes * 20 conformers per mode + 1 
input structure = 401 conformers). Since Cα-ENM Normal Mode Analysis is simple and 
computationally inexpensive, it provides a fast and automatable method to investigate the 
influence of protein conformation on rSASA and hence to further refine predictions about the 
accessibility of phosphorylation sites. 
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